BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1210301)

  • 21. [Treatment of chronic active hepatitis by 6-mercaptopurine and immuran (azathioprine)].
    Aprosina ZG; Mukhin AS
    Sov Med; 1972 Feb; 35(2):94-7. PubMed ID: 5039432
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience in the use of the Soviet drug riboxin in therapeutic practice].
    Komarov FI; Ol'binskaia LI; Vartanova OA; Ovchinnikova LV; Pogromov AP
    Sov Med; 1979 Dec; (12):82-3. PubMed ID: 531611
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of active chronic hepatitis with 6-mercaptopurine.
    Sjöberg KH; Welin G
    Acta Hepatosplenol; 1967; 14(3):157-62. PubMed ID: 4172443
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative evaluation of biochemical tests to determine the activity of the pathological process in patients with chronic hepatitis and cirrhosis of the liver who are receiving glucocorticoid therapy].
    Shul'man VSh; Tatarinova OM; Barenblat GZ
    Ter Arkh; 1969 Nov; 41(11):88-93. PubMed ID: 5384756
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of prednisolone on the blood coagulation system in chronic hepatitis].
    Krutovskaia OV
    Klin Med (Mosk); 1967 Aug; 45(8):70-3. PubMed ID: 5610475
    [No Abstract]   [Full Text] [Related]  

  • 27. [Behavior of immunoglobulins in the immunosuppressive therapy of liver diseases].
    Bauch K; Zimmermann S; Lewicki I; Büttner W
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2135-7. PubMed ID: 4650683
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adrenal cortical function in chronic hepatitis and liver cirrhosis patients during treatment by interstitial electrophoresis].
    Liashuk PM; Glibka AZ
    Vrach Delo; 1985 Oct; (10):28-30. PubMed ID: 4090426
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of chronic hepatitis and liver cirrhosis].
    Kommerell B
    Med Welt; 1974 Nov; 25(46):1904-10. PubMed ID: 4456135
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunodepressants in chronic liver diseases (a review of the literature and the authors' own data)].
    Podymova SD; Nasonov EL
    Ter Arkh; 1976; 48(3):40-8. PubMed ID: 795076
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 32. [The treatment of inflammatory liver diseases with 6-mercaptopurine (6-MP)].
    Weinreich J
    Acta Hepatosplenol; 1967; 14(4):189-98. PubMed ID: 5589685
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of the in vitro effect of hydrocortisone and D-penicillamine on the liver of patients with chronic hepatitis and liver cirrhosis].
    Gichev IuP; Bakulina LF
    Ter Arkh; 1980; 52(7):113-7. PubMed ID: 7404399
    [No Abstract]   [Full Text] [Related]  

  • 34. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mesenchyma-suppressing therapy of chronic aggressive hepatitis].
    Gros H; Zwirner K; Herzog W
    Med Klin; 1972 Oct; 67(40):1277-82. PubMed ID: 4638147
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preliminary results of immunosuppressive treatment in chronic liver diseases].
    Perings E; Hunstein W; Creutzfeldt W
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):209-12. PubMed ID: 5732398
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contribution on the therapy of chronic liver parenchymal damage with 6-mercaptopurine].
    Mott R; Knief J; Faul J
    Med Klin; 1968 Sep; 63(36):1422-8. PubMed ID: 5729432
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experiences with P-Carboxyphenylglycylaminoacetonitrile in refractory].
    Ota Y; Endo H
    Saishin Igaku; 1969 Jan; 24(1):185-7. PubMed ID: 5777190
    [No Abstract]   [Full Text] [Related]  

  • 39. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experiences with 6-mercaptopurine therapy in active chronic hepatopathies].
    Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Zimmermann HB
    Dtsch Z Verdau Stoffwechselkr; 1969; 22():89-95. PubMed ID: 5380092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.